dc.creatorFigueroa Figueroa, Mónica
dc.creatorTroncoso, Sofía
dc.creatorToledo Toledo, Gladys Luisa
dc.creatorFaúndez,
dc.creatorAcuña Acuña, Jeannette
dc.date.accessioned2019-01-29T17:51:03Z
dc.date.available2019-01-29T17:51:03Z
dc.date.created2019-01-29T17:51:03Z
dc.date.issued2002
dc.identifierJournal of Medical Microbiology, Volumen 51, Issue 4, 2018, Pages 300-304
dc.identifier00222615
dc.identifier10.1099/0022-1317-51-4-300
dc.identifierhttps://repositorio.uchile.cl/handle/2250/163494
dc.description.abstractThe objective of this study was to evaluate the prevalence of antibodies to Helicobacter pylori CagA and VacA proteins and correlate this prevalence with gastric diseases in colonised Chileans. The study was performed in 418 adults colonised with H. pylori: 316 with gastroduodenal pathology (152 duodenal ulcer, 14 gastric cancer and 150 gastritis patients) and 102 asymptomatic subjects. Serum IgG antibodies to H. pylori were determined by enzyme immunoassay (EIA). Antibodies to VacA and CagA proteins were detected by Western blotting. In a subgroup of the patients, the vacuolating activity was determined by HeLa cell assay and the CagA product was confirmed by PCR assay. IgG antibodies to both VacA and CagA proteins of H. pylori were found in 270 (85%) of 316 colonised gastric patients and in 72 (71%) of 102 asymptomatic subjects. Colonisation with virulent strains was significantly higher among duodenal ulcer and gastric cancer patients than in gastritis patients or asymptomatic subje
dc.languageen
dc.publisherLippincott Williams and Wilkins
dc.rightshttp://creativecommons.org/licenses/by-nc-nd/3.0/cl/
dc.rightsAttribution-NonCommercial-NoDerivs 3.0 Chile
dc.sourceJournal of Medical Microbiology
dc.subjectMicrobiology
dc.subjectMicrobiology (medical)
dc.titlePrevalence of serum antibodies to Helicobacter pylori VacA and CagA and gastric diseases in Chile
dc.typeArtículos de revistas


Este ítem pertenece a la siguiente institución